When HAE runs in the family, TAKHZYRO may be an option

TAKHZYRO is the first preventive treatment indicated for children with HAE 2 years of age and older. This means it could be a preventive option for you and your family members with HAE.

Imageoverlay
Patient portrayal.

TAKHZYRO is the #1 prescribed preventive HAE treatment*

*Based on total patients on HAE preventive treatments according to US third-party industry healthcare data.

Prescribed to 4,500+ people since 2018, including 130+ pediatric patients as young as 2 years of age since 2023†

†The number of patients prescribed TAKHZYRO is based on third-party US specialty pharmacy data.

Established safety profile from a 26-week study of 125 adults and adolescents (≥12 years of age) with HAE and a 52-week study of 21 children (2 to <12 years of age) with HAE. Learn more about the clinical study results.
Dosing once every 2 weeks for people 6 years of age and up, or every 4 weeks for children 2 to <6 years of age. Learn more about dosing.

When multiple members of the family are on TAKHZYRO, you can all navigate your treatment journey together.

Looking for information about TAKHZYRO for you or your family member with HAE?

DOWNLOAD

DESCARGAR

My daughter and I do our injection together. We set out everything and have a routine that really helps her through it.”

Eric, a real HAE patient

His TAKHZYRO experience started in 2018

I really like the fact that my daughter and I are taking the same preventive treatment."

SynToia, a real HAE patient

Her TAKHZYRO experience started in 2021

See if TAKHZYRO might be an option for you or your family members.

account
2574028764001
player
SykGTiz2b
video
6400058820112
Play Video: See if TAKHZYRO might be an option for you or your family members

To report SUSPECTED ADVERSE REACTIONS, contact Dyax Corp., a Takeda company, at 1-877-TAKEDA-7 (1-877-825-3327), or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

HAE runs in their family. So could the TAKHZYRO experience.

Learn about the hereditary nature of HAE and talk to your doctor about TAKHZYRO and if it may be an option for you and your loved ones.

Every family has shared genes. The smile gene. The height gene. The curly hair gene. The lack-of-hair gene. And for some, the HAE gene.

These families also share their choice of TAKHZYRO, the first prescription medication used to prevent HAE attacks in people 2 years of age and older.

In the clinical study, people taking TAKHZYRO had 87% fewer HAE attacks, with an average monthly attack rate of 0.3 with TAKHZYRO versus 2.0 with placebo.

TAKHZYRO may cause serious side effects, including allergic reactions. Call a doctor right away if you experience wheezing, difficulty breathing, chest tightness, fast heartbeat, faintness, rash, or hives. The most common side effects were injection site reactions (such as pain, redness, and bruising), upper respiratory infection, headache, rash, dizziness, diarrhea, and muscle aches.

So if you or a member of your family have HAE, talk to your doctor to see if fewer attacks are possible with TAKHZYRO. Join the community of people who are managing their HAE attacks with TAKHZYRO.

Ready to talk to your doctor about TAKHZYRO for you or your family member with HAE?

CONVERSATION STARTER